查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1620351

Aralelin 的全球市场规模：按类型、应用、地区、范围和预测

Global Alarelin Market Size By Type, By Applications, By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

Aralelin 市场规模及预测

2024 年 Ararelin 市场规模为 26 亿美元，预计到 2031 年将达到 57 亿美元，2024-2031 年预测期间复合年增长率为 4.4%。Aralelin 主要用于临床研究，以评估药物在生殖和性研究中对动物体的影响。子宫内膜异位症盛行率的上升，加上医疗保健研究的不断增加，正在推动 Ararelin 市场向前发展。Ararelin 的使用可能会引起一些副作用和其他医疗併发症，这可能会阻碍市场成长。预测期内的全球 Aralelin 市场报告提供了对市场的整体评估。它对关键细分市场、趋势、市场推动因素、阻碍因素、竞争格局以及在市场中发挥关键作用的因素进行了全面分析。

全球 Aralelin 市场定义

Aralelin 是一种释放激素，也称为促性腺激素。它是一种合成的 LH-RH 激动剂，在体外、体内和诱导排卵时的浓度均高于 LH-RH。它是一种常用于治疗子宫内膜异位症和子宫肌瘤的药物。Aralelin主要用于临床研究，研究药物对动物体的影响，用于性和生殖方面的研究。

根据医学建议，Aralelin可以提高男性睪固酮水平，治疗女性子宫内膜异位症，增强脑下垂体产生更多LH和FSH，帮助减轻老化症状，并帮助解决生殖问题。Aralelin 被批准用于兔子阴道内给药，以在人工授精期间诱导排卵，剂量高达 50 克/隻。

Aralelin全球市场概况

子宫内膜异位症盛行率的上升和医疗保健研究的增加正在推动 Ararelin 市场向前发展。子宫内膜异位症常见于接受输卵管绝育术并已证明具有生育能力的女性。一般人群中子宫内膜异位症的确切发生率尚不清楚。盛行率估计是基于患病可能性较高的手术族群。此外，男性的睪固酮水平有所增加。这种药物易于使用，可治疗女性子宫内膜异位症。增加脑下垂体产生 LH 和 FSH。此外，与其他胜肽一样，Aralelin 可以减轻老化症状。解决女性生殖问题的最佳方法将推动预测期内全球 Ararelin 市场的整体成长。

Ararelin 的使用有一些副作用，还会引起其他健康併发症，这可能会限制市场成长。Ararelin 的副作用包括口干、关节问题、过量服用导致的过多水分滞留、注射部位周围皮肤疼痛或发痒、饥饿感增加以及体重减轻或增加。此外，广泛的头痛、肾痛、感觉丧失和血压过高正在阻碍全球 Ararelin 市场的整体成长。此外，COVID-19 大流行将扰乱生产。由于国家停工、边境关闭以及严格的社会试错措施导致市场成长受阻，Ararelin 遭受了巨大损失。

目录

第1章 Aralelin 的全球市集：简介

  • 市场概况
  • 调查范围
  • 先决条件

第 2 章执行摘要

第3章 验证市场研究研究方法

  • 数据挖掘
  • 确认
  • 初步面试
  • 数据源列表

第4章阿拉瑞林全球市场展望

  • 概述
  • 市场动态
    • 促进因素
    • 阻碍因素
    • 机会
  • 波特的五力模型
  • 价值链分析

第5章 Aralelin 的全球市场：按类型

  • 概述
  • 阿拉瑞林 98%
  • 阿拉瑞林 99%
  • 其他

第6章 Aralelin 的全球市场：依应用分类

  • 概述
  • 子宫肌瘤
  • 子宫内膜异位症
  • 其他

第7章 Aralelin 全球市场：按地区

  • 概述
  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 亚太其他地区
  • 世界其他地区
    • 拉丁美洲
    • 中东/非洲

第8章阿拉瑞林全球竞争状况

  • 概述
  • 各公司市场排名
  • 主要发展策略

第9章 公司简介

  • Hangzhou Longshine Bio-Tech
  • Rixing Chemical CO.LTD
  • Santa Cruz Biotechnology
  • JSN Chemicals
  • Chemwill Asia Co
  • ALB Technology Limited
  • LGM PharmaLtd
  • BBCA Group

第10章 主要进展

  • 产品发布/开发
  • 併购
  • 业务拓展
  • 伙伴关係和联盟

第11章附录

  • 相关研究
简介目录
Product Code: 11492

Alarelin Market Size And Forecast

Alarelin Market size was valued at USD 2.6 Billion in 2024 and is projected to reach USD 5.7 Billion by 2031, growing at a CAGR of 4.4 % during the forecast period 2024-2031. Alarelin is mainly used in clinical research to evaluate the drug's effects on an animal's body in reproductive and sexual kinds of research. The rise in the prevalence of endometriosis, combined with growing healthcare research, is boosting the Alarelin Market forward. The use of alarelin can have some adverse effects or cause other medical complications, which may inhibit the market growth. Over the forecasted period. The Global Alarelin Market report provides a holistic evaluation of the market. The report comprehensively analyzes key segments, trends, drivers, restraints, competitive landscape, and factors playing a substantial role in the market.

Global Alarelin Market Definition

Alarelin, also known as gonadotropin, is a releasing hormone. It is a synthetic LH-RH agonist present in higher concentrations than LH-RH in vitro, in vivo, and in ovulation inductions. It is a type of medication that is commonly used to treat endometriosis or hysteromyoma. Alarelin is primarily used in clinical research to study the drug's effects on an animal's body for circumstances related to sexual and reproductive research.

With a medical recommendation, alarelin enhances testosterone levels in men, treats endometriosis in women, enhances the pituitary gland to generate more LH and FSH, aids in the reduction of aging symptoms, and resolves reproduction issues in women. Alarelin is approved for use in rabbits for intravaginal administration to induce ovulation during artificial insemination at doses of up to 50 g/doe.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Alarelin Market Overview

The rising prevalence of endometriosis, combined with growing healthcare research, is propelling the Alarelin Market forward. Endometriosis is found in females enduring tubal sterilization procedures who have demonstrated fertility. The exact incidence of endometriosis in the general population is uncertain. Prevalence estimates are based on a surgical population with a high probability of disease. Moreover, Men's testosterone levels increased. The medication is simple to use and treats female Endometriosis. Increases the production of LH and FSH by the pituitary gland. Furthermore, Alarelin, like other peptides, enables the reduction of aging symptoms. The best approach for female reproduction concerns leading to driving the overall growth of the Global Alarelin Market throughout the projected period.

Alarelin use has some adverse side effects or leads to other health complications, which may limit the market growth. Some of the side effects of alarelin include dry mouth, joint problems, excessive water retention caused by overdosing, pains or itchy skin around the site of injection, increased hunger, as well as weight loss/gain. Furthermore, Extensive headaches, Kidney pain, Loss of sensation, and Blood pressure are too high leading to inhibiting the overall growth of the Global Alarelin Market. Furthermore, The COVID-19 pandemic disrupts production. Alarelin has suffered significantly as a result of national lockdowns, border crossing seals, and rigid social trying-to-distance measures leading to hindering the growth of the market.

Global Alarelin Market Segmentation Analysis

The Global Alarelin Market is Segmented Based on Type, Applications, And Geography.

Alarelin Market, By Type

  • Alarelin 98%
  • Alarelin 99%
  • Other
  • Based on Type, The market is classified into Alarelin 98%, Alarelin 99%, and Other. The Alarelin 98% has the highest growing segment of the Global Alarelin Market. Alarelin is used to treat endometriosis and may stimulate ovulation. It is in charge of the pituitary gland's secretion of gonadotropins, luteinizing hormone, and follicle-stimulating hormone

Alarelin Market, By Application

  • Uterine Fibroids
  • Endometriosis
  • Others

Based on Applications, The market is classified into Uterine Fibroids, Endometriosis, and Others. Uterine Fibroids have the highest-growing segment of the Global Alarelin Market. Uterine fibroids are noncancerous uterine lesions that most commonly appear during pregnancy. Uterine fibroids, also known as leiomyomas or myomas, are not linked with an increased incidence of uterine cancer and also never increase the risk of cancer Endometriosis is a painful disorder in which tissue similar to the endometrium, which generally lines the inside uterus, starts growing outside the uterus.

Alarelin Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world
  • On the basis of Geography, The Global Alarelin Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America has the largest growing segment of the Alarelin Market. North America and Europe have the largest growing segment of the Global Alarelin Market throughout the forecasted period.

Key Players

  • The "Global Alarelin Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as
  • Hangzhou Longshine Bio-Tech, Rixing Chemical CO., LTD, Santa Cruz Biotechnology, JSN Chemicals, Chemwill Asia Co, BBCA Group, ALB Technology Limited, LGM Pharma Ltd., Henan Tianfu Chemical Co., Ltd., And Shanghai Soho-Yiming Pharmaceuticals.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

TABLE OF CONTENTS

1. INTRODUCTION OF GLOBAL ALARELIN MARKET

  • 1.1. Overview of the Market
  • 1.2. Scope of Report
  • 1.3. Assumptions

2. EXECUTIVE SUMMARY

3. RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1. Data Mining
  • 3.2. Validation
  • 3.3. Primary Interviews
  • 3.4. List of Data Sources

4. GLOBAL ALARELIN MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5. GLOBAL ALARELIN MARKET, BY TYPE

  • 5.1. Overview
  • 5.2. Alarelin 98%
  • 5.3. Alarelin 99%
  • 5.4. Others

6 GLOBAL ALARELIN MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Uterine Fibroids
  • 6.3 Endometriosis
  • 6.4 Other

7 GLOBAL ALARELIN MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.3 Canada
    • 7.2.4 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Rest of the World
    • 7.5.1 Latin America
    • 7.5.2 Middle East and Africa

8 GLOBAL ALARELIN COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Ranking
  • 8.3 Key Development Strategies

9. COMPANY PROFILES

  • 9.1 Hangzhou Longshine Bio-Tech
    • 9.1.1 Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Outlook
    • 9.1.4 Key Developments
  • 9.2 Rixing Chemical CO.LTD
    • 9.2.1 Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Outlook
    • 9.2.4 Key Developments
  • 9.3 Santa Cruz Biotechnology
    • 9.3.1 Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Outlook
    • 9.3.4 Key Developments
  • 9.4 JSN Chemicals
    • 9.4.1 Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Outlook
    • 9.4.4 Key Developments
  • 9.5 Chemwill Asia Co
    • 9.5.1 Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Outlook
    • 9.5.4 Key Developments
  • 9.6 ALB Technology Limited
    • 9.6.1 Overview
    • 9.6.2 Financial Performance
    • 9.6.3 Product Outlook
    • 9.6.4 Key Developments
  • 9.7 LGM PharmaLtd
    • 9.7.1 Overview
    • 9.7.2 Financial Performance
    • 9.7.3 Product Outlook
    • 9.7.4 Key Developments
  • 9.8 BBCA Group
    • 9.8.1 Overview
    • 9.8.2 Financial Performance
    • 9.8.3 Product Outlook
    • 9.8.4 Key Developments

10 KEY DEVELOPMENTS

  • 10.1 Product Launches/Developments
  • 10.2 Mergers and Acquisitions
  • 10.3 Business Expansions
  • 10.4 Partnerships and Collaborations

11 Appendix

  • 11.1 Related Research